XRAY Stock Declines on Q3 Earnings Miss & Lower 2025 EPS View

Key Takeaways XRAY's Q3 EPS fell 26.5% year over year, missing the consensus estimate by 17.8%.XRAY's revenues declined 4.9% to $904 million, with weakness in most segments except Wellspect Healthcare.XRAY lowered 2025 EPS guidance to about $1.60, while maintaining its sales outlook of $3.6-$3.7 billion.DENTSPLY SIRONA Inc. (XRAY) reported third-quarter 2025 adjusted earnings per share (EPS) of 37 cents, down 26.5% year over year. The bottom line missed the Zacks Consensus Estimate by 17.8%.GAAP loss per sh ...